PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for January 29, 2009 Add to my Yahoo! Subscribe to this News Feed Subscribe to this News Feed   
 

New Software Technology Report for Medical Device Makers: How to Manage an FDA Controlled Software Project

Full Spectrum Software, a leading software developer for medical device makers, announced the release of their second in a series of free Software Technical Reports, How to Manage an FDA Controlled Software Project. Download Report Here This free Software Technical Report covers best practices in software team communications, software methodologies and managing and organizing software engineering and software quality assurance teams.

Southborough, MA (Vocus/PRWEB ) January 29, 2009 -- Full Spectrum Software, a leading software developer for medical device makers, announced the release of their second in a series of free Software Technical Reports, How to Manage an FDA Controlled Software Project. Medical device makers face many challenges in developing software for sophisticated medical devices that must follow FDA guidelines for software quality. Full Spectrum Software has been developing software for medical device companies for over a decade. This free Software Technical Report covers best practices in software team communications, software methodologies, managing and organizing software engineering and software quality assurance teams. In addition, it offers some proven tips and techniques for creating high performing software project teams for medical device companies.

Full Spectrum Software
Full Spectrum Software

The Software Technical Report is based on Full Spectrum’s work with hundreds of medical device companies. More information about Full Spectrum’s software development projects for medical device makers can be seen here: See Project Examples

For managers of software development at medical device companies, this report shows what techniques work well and more importantly, what techniques don’t work in developing software for FDA controlled software projects. This comprehensive report is a must read for any manager responsible for developing software for medical devices. It provides practical advice for working with medical device software consulting firms, managing internal software teams and the pros and cons of software development methodologies such as Agile software development.

"How to Manage an FDA Controlled Software Project" is available on Full Spectrum Software’s website and can be downloaded for free here Download Current Report Registration is not required. It is the second in a series of 10 Software Technical Reports to be published for software managers at medical device companies. The first Software Technical Report Software Obfuscation for Medical Device Companies can be found here Download First Technical Report.

Contact:
Ken Carson
Vice President, Client Services
508-620-6400 X208

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1Ib3JyLUxvdmUtRW1wdC1GYWx1LVNpbmctWmVybw==

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


Other Releases by this Member
OPTIONS
Printer Friendly Printer Friendly Version
Adobe PDF Download PDF Version
Adobe PDF Download Reader Version
Blog This BlogThis
Share This ShareThis
CONTACT INFORMATION
Ken Carson
Full Spectrum Software
508-620-6400
Email us Here
View Our Newsroom
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move